+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Alexion Pharmaceuticals - logo

Alexion is a global biopharmaceutical company focused on developing and delivering life-transforming therapies for patients with devastating and rare diseases. Alexion developed Soliris for the treatment of patients with paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome. Soliris is approved in more than 50 countries for PNH and more than 40 countries for aHUS. Alexion's company headquarters are based Cheshire, Connecticut, United States.

DNA Repair Drugs Market Report 2025 - Product Thumbnail Image

DNA Repair Drugs Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
From
Multiple Sclerosis Drugs Market Report 2025 - Product Thumbnail Image

Multiple Sclerosis Drugs Market Report 2025

  • Report
  • April 2025
  • 250 Pages
  • Global
From
Myasthenia Gravis - Pipeline Insight, 2024 - Product Thumbnail Image

Myasthenia Gravis - Pipeline Insight, 2024

  • Clinical Trials
  • June 2024
  • 80 Pages
  • Global
From
Neuromyelitis Optica Spectrum Disorder (NMOSD) - Pipeline Insight, 2024 - Product Thumbnail Image

Neuromyelitis Optica Spectrum Disorder (NMOSD) - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 50 Pages
  • Global
From
Transverse Myelitis - Pipeline Insight, 2024 - Product Thumbnail Image

Transverse Myelitis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
From
Sandhoff Disease Market Report and Forecast 2024-2032 - Product Thumbnail Image

Sandhoff Disease Market Report and Forecast 2024-2032

  • Report
  • February 2024
  • 180 Pages
  • Global
From
From
Loading Indicator